| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |